These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 17351760)

  • 1. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.
    Negi VS; Elluru S; Sibéril S; Graff-Dubois S; Mouthon L; Kazatchkine MD; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Clin Immunol; 2007 May; 27(3):233-45. PubMed ID: 17351760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IVIG-mediated effector functions in autoimmune and inflammatory diseases.
    Galeotti C; Kaveri SV; Bayry J
    Int Immunol; 2017 Dec; 29(11):491-498. PubMed ID: 28666326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of natural antibodies in immune homeostasis: IVIg perspective.
    Vani J; Elluru S; Negi VS; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Autoimmun Rev; 2008 Jun; 7(6):440-4. PubMed ID: 18558359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy in dermatologic disorders.
    Cakmak SK; Gül U; Gönül M; Kiliç A; Soylu S
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):75-84. PubMed ID: 18691136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms.
    Bayry J; Dasgupta S; Misra N; Ephrem A; Duong Van Huyen JP; Delignat S; Hassan G; Caligiuri G; Nicoletti A; Lacroix-Desmazes S; Kazatchkine MD; Kaveri S
    Int Immunopharmacol; 2006 Apr; 6(4):528-34. PubMed ID: 16504915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immunomodulatory action of intravenous immunoglobulin in autoimmune and systemic inflammatory diseases.
    Vassilev T; Kazatchkine MD
    Ther Apher; 1997 Feb; 1(1):38-41. PubMed ID: 10225779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of immune regulation by IVIG.
    Ballow M
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):509-15. PubMed ID: 25337683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation of autoimmune disorders: the role of intravenous immunoglobulins.
    Luzi G; Ferrara R
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():189-95. PubMed ID: 8013987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders.
    Larroche C; Chanseaud Y; Garcia de la Pena-Lefebvre P; Mouthon L
    BioDrugs; 2002; 16(1):47-55. PubMed ID: 11909001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases].
    Mouthon L; Lacroix-Desmazes S; Pashov A; Kaveri SV; Kazatchkine MD
    Rev Med Interne; 1999; 20 Suppl 4():423s-430s. PubMed ID: 10522317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.